Study on Nipocalimab for Adults with Active Inflammatory Muscle Diseases
- Substances:Nipocalimab
Hungary- Participants:18–64 years · 65+ years
- Substances:Nipocalimab
Rare diseases
Investigational molecules
Locations
HungaryStudy of Pembrolizumab and Enfortumab Vedotin with Surgery vs. Surgery Alone for Patients with Muscle-Invasive Bladder Cancer Who Cannot or Choose Not to Use Cisplatin
HungaryStudy on Preventing Infections After Abdominal Surgery Using D-PLEX with Doxycycline Hyclate for Patients Undergoing Abdominal Surgery
HungaryStudy on the Safety and Tolerability of Epcoritamab with Drug Combination for Patients with B-cell Non-Hodgkin Lymphoma
Hungary
HungaryStudy of Venetoclax and Azacitidine for Maintenance Therapy in Patients with Acute Myeloid Leukemia in First Remission After Chemotherapy
HungaryStudy on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation
HungaryStudy of TransCon TLR7/8 Agonist, TransCon IL-2 β/γ, and Pembrolizumab for Patients with Advanced Head and Neck Cancer
Hungary
HungaryStudy on the Safety and Effectiveness of Ocrelizumab vs. Fingolimod for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis
HungaryStudy on How Concizumab Works for Patients with Hemophilia A or B Without Inhibitors
HungaryStudy Comparing Radium-223 Dichloride with Abiraterone Acetate, Enzalutamide, and Prednisone in Patients with Advanced Prostate Cancer Spread to the Bone
HungaryTell us about your condition – we search every trial in Europe and connect you with the right site.